Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Rühl, Ricarda ^a   Lüdemann, Lutz ^b   Czarnecka, Anna ^c   Streitparth, Florian ^b   Seidensticker, Max ^a   Mohnike, Konrad ^a   Pech, Maciej ^a   Wust, Peter ^b   Ricke, Jens ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; IOPROMIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CATHETER; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; FLUOROSCOPY; HUMAN; LIVER CELL; LIVER DYSFUNCTION; LIVER METASTASIS; LIVER PARENCHYMA; LIVER WEIGHT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; BILE DUCT TUMOR; BREAST TUMOR; COLORECTAL TUMOR; FOLLOW UP; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BRACHYTHERAPY; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOMETALLIC COMPOUNDS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952737409     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-44     Document Type: Article

References (33)

1. Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001, 19:164-170.
2. Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009, 27:1585-1591. 10.1200/JCO.2008.20.0600, 19255313.
3. Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R, et al. Computed Tomography-Guided High-Dose-Rate Brachytherapy in Hepatocellular Carcinoma: Safety, Efficacy, and Effect on Survival. Int J Radiat Oncol Biol Phys 2010,
4. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004, 58:1496-1505. 10.1016/j.ijrobp.2003.09.024, 15050329.
5. Ricke J, Mohnike K, Pech M, Seidensticker M, Ruhl R, Wieners G, et al. Local Response and Impact on Survival After Local Ablation of Liver Metastases from Colorectal Carcinoma by Computed Tomography-Guided High-Dose-Rate Brachytherapy. Int J Radiat Oncol Biol Phys 2010,
6. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27:1572-1578. 10.1200/JCO.2008.19.6329, 19255321.
7. Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002, 53:810-821.
8. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation Hepatitis. Am J Roentgenol Radium Ther Nucl Med 1965, 93:200-208.
9. Wharton JT, Delclos L, Gallager S, Smith JP. Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 1973, 117:73-80.
10. Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 2005, 15:279-283. 10.1016/j.semradonc.2005.04.005, 16183482.
11. Robertson JM, Lawrence TS, Dworzanin LM, Andrews JC, Walker S, Kessler ML, et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993, 11:1286-1293.
12. Cheng JC, Wu JK, Huang CM, Liu HS, Huang DY, Cheng SH, et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys 2002, 54:156-162. 10.1016/S0360-3016(02)03424-7, 12182986.
13. Ricke J, Seidensticker M, Ludemann L, Pech M, Wieners G, Hengst S, et al. In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 2005, 62:776-784.
14. Wybranski C, Seidensticker M, Mohnike K, Kropf S, Wust P, Ricke J, et al. In vivo assessment of dose volume and dose gradient effects on the tolerance dose of small liver volumes after single-fraction high-dose-rate 192Ir irradiation. Radiat Res 2009, 172:598-606. 10.1667/RR1773.1, 19883228.
15. de Haen C, Lorusso V, Luzzani F, Tirone P. Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat. Acad Radiol 1995, 2:232-238. 10.1016/S1076-6332(05)80171-0, 9419554.
16. Kirchin MA, Pirovano GP, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 1998, 33:798-809. 10.1097/00004424-199811000-00003, 9818314.
17. de Haen C, Gozzini L. Soluble-type hepatobiliary contrast agents for MR imaging. J Magn Reson Imaging 1993, 3:179-186. 10.1002/jmri.1880030130, 8428085.
18. Planchamp C, Gex-Fabry M, Becker CD, Pastor CM. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers. Invest Radiol 2007, 42:513-521. 10.1097/RLI.0b013e318036b450, 17568274.
19. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995, 31:1237-1248.
20. Fajardo LF, Colby TV. Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 1980, 104:584-588.
21. Reed GB, Cox AJ. The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 1966, 48:597-611. 1916442, 5327788.
22. Ricke J, Wust P, Wieners G, Beck A, Cho CH, Seidensticker M, et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004, 15:1279-1286.
23. Studholme C, Hill DL, Hawkes DJ. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys 1997, 24:25-35. 10.1118/1.598130, 9029539.
24. Rohlfing T, West JB, Beier J, Liebig T, Taschner CA, Thomale UW. Registration of functional and anatomical MRI: accuracy assessment and application in navigated neurosurgery. Comput Aided Surg 2000, 5:414-425. 10.3109/10929080009148901, 11295854.
25. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989, 62:679-694. 10.1259/0007-1285-62-740-679, 2670032.
26. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
27. Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den BW. Fractionation parameters for human tissues and tumors. Int J Radiat Biol 1989, 56:701-710. 10.1080/09553008914551931, 2573666.
28. Thames HD, Hendry JH, Moore JV, Ang KK, Travis EL. The high steepness of dose-response curves for late-responding normal tissues. Radiother Oncol 1989, 15:49-53. 10.1016/0167-8140(89)90117-5, 2748942.
29. Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den BW. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol 1990, 19:219-235. 10.1016/0167-8140(90)90149-Q, 2281152.
30. Thames HD, Withers HR, Peters LJ, Fletcher GH. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982, 8:219-226.
31. teel GG, Deacon JM, Duchesne GM, Horwich A, Kelland LR, Peacock JH. The dose-rate effect in human tumour cells. Radiother Oncol 1987, 9:299-310. 10.1016/S0167-8140(87)80151-2, 3317524.
32. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985, 58:515-528. 10.1259/0007-1285-58-690-515, 4063711.
33. Field KM, Dow C, Michael M. Part I: Liver function in oncology: biochemistry and beyond. Lancet Oncol 2008, 9:1092-1101. 10.1016/S1470-2045(08)70279-1, 19012858.